V-Guard Industries has approved the grant of 16,747 employee stock options under its ESOS 2013 scheme. This grant, approved by the Nomination and Remuneration Committee on October 28, 2026, allows eligible employees to subscribe to equity shares at a nominal exercise price of ₹1 per option. The options vest over a period of up to four years, subject to continued employment and performance criteria, and can be exercised within six years from the vesting date.
V-Guard Industries Approves Employee Stock Option Grant
V-Guard Industries announced today, October 28, 2026, that its Nomination and Remuneration Committee has approved the grant of options to eligible employees under its Employee Stock Option Scheme (ESOS) 2013. A total of 16,747 options have been granted, providing employees with the right to subscribe to equity shares of the company.
Key Details of the ESOP Grant
The grant is compliant with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The options represent the right to apply for an equivalent number of equity shares with a face value of ₹1 each. The exercise price for these options is set at ₹1 per option.
Vesting and Exercise Period
The vesting of these options will occur over a period not exceeding four years, based on time and performance criteria. Time-based options will vest periodically, while performance options will vest in the final year, contingent on meeting performance criteria. Employees will have a window of 6 years from the date of vesting to exercise their granted options. If options lapse or are cancelled for any reason, the Nomination and Remuneration Committee will, at its discretion, decide on the re-issuance of such options.
Administration and Terms of ESOS 2013
The ESOS 2013 is administered by the Nomination and Remuneration Committee. Options granted under this scheme will vest in not less than one year and not more than four years from the grant date. Vesting is conditional upon continued employment with V-Guard Industries and the fulfillment of any performance criteria. The exercise price is determined by the Committee and will not be less than the face value of the shares nor more than the prevailing market value as of the grant date.
Source: BSE
